Related Experiment Video
Updated: Aug 5, 2026

07:31
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
Published on: May 9, 2014
12.2K
Validation of In vivo Diode Characteristics at Extended Source to Surface Distance for Total Body Irradiation
K Nithin1, P M Jayadevan1, Dhanya1
1Department of Radiation Oncology, Rajagiri Hospital, Aluva, Kerala, India.
Journal of Medical Physics
|October 30, 2025
Summary
ISORAD diode detectors show consistent performance for in vivo dosimetry in total body irradiation (TBI) treatments up to 400 cm source-to-surface distance (SSD). These findings support their use in TBI patient dosimetry, even beyond manufacturer limits.
Area of Science:
- Medical Physics
- Radiation Oncology
- Dosimetry
Background:
- Total body irradiation (TBI) requires precise dosimetry, especially for extended source-to-surface distance (SSD) treatments.
- The application of ISORAD diode detectors for in vivo dosimetry in TBI, particularly at extended SSDs, needs thorough investigation.
- Manufacturer specifications for ISORAD diode detectors have a 250 cm SSD limit, necessitating evaluation beyond this range.
Purpose of the Study:
- To evaluate the feasibility of using ISORAD diode detectors for in vivo dosimetry in TBI treatments at extended SSDs (up to 400 cm).
- To assess the operational characteristics of ISORAD diode detectors, including reproducibility, linearity, and dose rate dependence, up to 400 cm SSD.
- To compare the performance of ISORAD diode detectors with a Farmer chamber and validate their use in clinical TBI settings.
Main Methods:
- Four ISORAD-1163 n-type cylindrical diode detectors were characterized and compared with a 0.6cc Farmer chamber.
- Performance metrics including reproducibility, linearity, field size dependence, and dose rate dependence were assessed from 100 cm to 400 cm SSD.
- Post-irradiation signal drift, short-term reproducibility, signal stability, and directional dependence were monitored; a diode was used for in vivo TBI patient measurements.
Main Results:
- ISORAD diode detectors demonstrated acceptable dose rate effects (<0.91%), linearity (<0.99%), and reproducibility (<0.19%) up to 400 cm SSD.
- Minimal deviations in post-irradiation signal drift (<0.09%) and signal consistency (<0.09%) were observed.
- In vivo TBI patient measurements showed a maximum dose difference of 8.5% between calculated and actual diode readings.
Conclusions:
- ISORAD diode detectors exhibit consistent operational characteristics up to 400 cm SSD, exceeding manufacturer specifications.
- The study supports the applicability of these diodes for reliable in vivo dosimetry in total body irradiation treatments.
- Further investigation into directional dependence, particularly in the transverse plane beyond ± 30°, is warranted.

